Related Experiment Video

Updated: Nov 19, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.6K

Acceleration of cutaneous T-cell lymphoma following dupilumab administration

Kristen Russomanno1,2, Cynthia Marie Carver DeKlotz1

  • 1Department of Dermatology, Medstar Washington Hospital Center/Georgetown University Hospital, Chevy Chase, Maryland.

JAAD Case Reports
|February 3, 2021
PubMed
Abstract

No abstract available in PubMed .

Keywords:
CTCL, cutaneous T-cell lymphomaIL, interleukinatopic dermatitisbiologicscutaneous t-cell lymphomadrug reactiondupilumabmonoclonal antibodiesmycosis fungoides

More Related Videos

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

12.3K
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus05:44

Skin Biopsy for Diagnosing Discoid Lupus Erythematosus

Published on: June 10, 2025

482

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
861